精华制药 (002349)
JINGHUA PHARMACEUTICAL GROUP CO., LTD.
K-Line Chart
No K-line data available
Company NameJinghua Pharmaceutical Group Co., Ltd.
Listing Date2010-02-03
Issue Price19.8RMB
Registered Capital82967.490810k RMB
Legal RepresentativeYin Hongyu
Registered AddressNo. 9 Xingtai Road, Gangzha Economic Development Zone, Nantong City, Jiangsu Province
IndustryTraditional Chinese Medicine II
Main BusinessResearch, development, production, and sales of traditional Chinese patent medicine preparations, chemical APIs and intermediates, chemical pharmaceutical intermediates, Chinese medicinal materials and prepared slices, and biopharmaceuticals.
Company ProfileJinghua Pharmaceutical Group Co., Ltd. was established through the restructuring and reorganization of the former Nantong Zhongcheng Pharmaceutical Co., Ltd. (Nantong Traditional Chinese Medicine Factory), integrating the high-quality resources of Nantong Pharmaceutical General Factory (Nantong Pharmaceutical Factory, Nantong No. 2 Pharmaceutical Factory), and absorbing private capital from Nantong Zongyi Investment Co., Ltd. along with investments from natural persons. As a comprehensive modern GMP pharmaceutical company, it is becoming a key national enterprise in the production, sales, and R&D of APIs, pharmaceutical intermediates, Western medicine, and Chinese patent medicine preparations, and has ventured into the biopharmaceutical field.
Stock Details
1. Key Indicators
- Total Shares(W): 82967.49
- Circulating A-Shares(W): 81418.09
- Earnings Per Share(RMB): 0.2148
- Net Assets Per Share(RMB): 3.2617
- Operating Revenue(W RMB): 109228.54
- Total Profit(W RMB): 24304.74
- Net Profit Attributable to Parent(W RMB): 17637.27
- Net Profit Growth Rate(%): 7.39
- Weighted Return on Equity(%): 7.0000
- Operating Cash Flow Per Share(RMB): 0.2710
- Undistributed Profit Per Share(RMB): 1.1765
- Capital Reserve Per Share(RMB): 0.9865
2. Main Business
The main business covers:
- Research, production, and sales of traditional Chinese patent medicine preparations.
- Research, production, and sales of chemical APIs and intermediates.
- Research, production, and sales of chemical pharmaceutical intermediates.
- Research, production, and sales of Chinese medicinal materials and prepared slices.
3. Company Basic Information
- Company Name: Jinghua Pharmaceutical Co., Ltd.
- Listing Date: 2010-02-03
- Industry: Pharmaceutical Manufacturing
- Address: Floors 20-25, Building A, Guocheng Life Plaza, No. 198 Qingnian Middle Road, Chongchuan District, Nantong City, Jiangsu Province, China
- Website: www.ntjhzy.com
- Company Profile: The issuer was established as a joint stock company through the overall change of Nantong Jinghua Pharmaceutical Co., Ltd. In September 2007, with Nantong Industrial and Trade State-owned Assets Management Co., Ltd., Nantong Variety Investment Co., Ltd., Jiangsu Nantong Gangzha Economic Development Zone General Company, and 36 natural persons including Zhu Chunlin as promoters, the audited total net assets as of August 31, 2007, amounting to RMB 84,049,172.45, were converted into 60 million shares of Nantong Jinghua Pharmaceutical Co., Ltd. at a ratio of 1.4:1. The remaining RMB 24,049,172.45 was transferred to capital reserve. The promoters converted their respective equity interests in Jinghua Limited into shares of the joint stock company proportionally. The issuer completed the change registration at the Nantong Administration for Industry and Commerce on September 28, 2007, and obtained the Business License for Enterprise Legal Person with registration number 3206001100618. In March 2008, the issuer's business license registration number was changed to 320600000001352.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Nantong Industrial Holding Group Co., Ltd. | General Legal Person | 27999.47 | 34.39 |
| 2 | Jiangsu Nantong Gangzha Economic Development Zone Urban Construction Development Co., Ltd. | General Legal Person | 2982.60 | 3.66 |
| 3 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 685.55 | 0.84 |
| 4 | ChinaAMC CSI Traditional Chinese Medicine ETF | Fund | 363.07 | 0.45 |
| 5 | Penghua CSI Traditional Chinese Medicine ETF | Fund | 138.42 | 0.17 |
| 6 | BDO Shengli 6-Month Holding Period Hybrid Securities Investment Fund | Fund | 1.19 | 0.00 |
| 7 | BDO Hexiang Diversified Stable Bond Securities Investment Fund Class A | Fund | 1.13 | 0.00 |
5. Concept Sectors
- Lithium Battery
- Senior Care Concept
- Hepatitis Concept
- Innovative Drug
- Margin Trading & Securities Lending
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information